Zentalis Pharmaceuticals News

Latest Zentalis Pharmaceuticals Stock News & ZNTL Headlines

Zentalis Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Updates

5 days ago | globenewswire.com

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

11 days ago | globenewswire.com

Zentalis Pharmaceuticals Announces Meaningful Median Overall Survival Data in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer from DENALI Part 1b to be Presented at the ESMO Congress 2026

23 days ago | globenewswire.com

Zentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 Abstract

a month ago | globenewswire.com

Comparing Zentalis Pharmaceuticals (NASDAQ:ZNTL) and Redhill Biopharma (NASDAQ:RDHL)

a month ago | defenseworld.net

Leerink Partners Initiates Coverage on Zentalis Pharmaceuticals (NASDAQ:ZNTL)

a month ago | defenseworld.net

This Small Biotech's Cancer Drug Could Reach $1.3 Billion In Peak Sales

2 months ago | benzinga.com

Zentalis Pharmaceuticals, Inc. (ZNTL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

2 months ago | seekingalpha.com

BlackRock Inc. Invests $18.20 Million in Zentalis Pharmaceuticals, Inc. $ZNTL

2 months ago | defenseworld.net

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

2 months ago | globenewswire.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

ZNTL

Zentalis Pharmaceuticals

$ 1.70

1.19%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated a day ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Zentalis Pharmaceuticals News

Latest Zentalis Pharmaceuticals Stock News & ZNTL Headlines

Download App

People Also Watch

Explore our Tools